[1]
Lv, P-C.; Yang, Y-S.; Wang, Z-C. Recent progress in the development of small molecule c-Met inhibitors. Curr. Top. Med. Chem., 2019, 19(15), 1276-1288.
[2]
Duan, Y. liu, W.; Tian, L.; Mao, Y.; Song, C. Targeting tubulin-colchicine site for cancer therapy: Inhibitors, antibody-drug conjugates and degradation agents. Curr. Top. Med. Chem., 2019, 19(15), 1289-1304.
[3]
Hu, Y.S.; Han, X.; Liu, X.H. STAT3: A potential drug target for tumor and inflammation. Curr. Top. Med. Chem., 2019, 19(15), 1305-1317.
[4]
Guo, W-Y.; Zeng, S-M-Z.; Deora, G.S.; Li, Q-S.; Ruan, B-F. Estrogen receptor α (ERα)-targeting compounds and derivatives: Recent advances in structural modification and bioactivity. Curr. Top. Med. Chem., 2019, 19(15), 1318-1337.